News
-
-
-
PRESS RELEASE
Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement with Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia
Radius Pharmaceuticals grants Theramex exclusive commercialization rights to ELADYNOS® for osteoporosis treatment in select regions, expanding global market access -
PRESS RELEASE
Poster Presentation Describing the Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients to Take Place December 11, 2024 at San Antonio Breast Cancer Symposium (SABCS)
Jaguar Health's Napo Pharmaceuticals to present data on crofelemer in breast cancer patients at SABCS 2024. Additional analyses ongoing. Patient advocacy program also announced -
PRESS RELEASE
Déclaration des transactions sur actions propres réalisées du 2 au 6 décembre 2024 dans le cadre du programme de rachat d'actions
Découvrez les détails des opérations journalières par marché de l'émetteur Aubay via leur site internet. Aubay, ESN présente dans divers secteurs avec 7551 collaborateurs en 2024 -
-
PRESS RELEASE
bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions
bonyf achieves MDR certification, strengthening commitment to excellence in oral care solutions. The certification marks a new chapter in the pursuit of quality and safety standards for dental products -
-
-
